HER2-positive breast cancer, which accounts for 20-25 percent of breast cancer, has been known for poor treatment prognosis, as its tumor cells proliferate and metastasize actively and recur quickly even after treatment.However, the cure rate of HER2-positive breast cancer, especially in its early s
The government said it will reduce the interval between Covid-19 vaccinations from the current 120 days to 90 days, regardless of the number of vaccinations, from Thursday this week. The new measure comes after an analysis of neutralizing antibodies against the Omicron variant for high-risk groups s
JW Pharmaceutical said its U.S. research institute, JW Theriac, moved from San Diego to Cambridge Innovation Center (CIC) in Boston in the U.S.CIC is the world's renowned bio-health industry cluster where over 1,000 global pharmaceutical firms, rising start-ups, hospitals, and research institutions
SK Bioscience shares plummeted Wednesday morning after the company admitted that it had suspended production of SKYCovione, the first domestically developed Covid-19 vaccine.At 12:00 p.m., on Wednesday, SK Bioscience shares stood at 79,500 won ($58.80), down 8.3 from the previous trading day.News re
The one-year grace period granted by the financial regulator to Dx&Vx, a molecular diagnostics company, to improve business irregularities has ended.According to the Korea Exchange (KRX), the improvement period for Dx&Vx ended on Tuesday.Now, Dx&Vx must submit documents detailing how it implemented
Health officials have confirmed the fourth case of monkeypox in Korea. The fourth confirmed patient is a medical professional infected while taking a sample of the third patient.The Korea Disease Control and Prevention Agency (KDCA) said Tuesday that a medical staff who worked in the isolated room o
Coreline Soft, a provider of medical artificial intelligence (AI) solutions, said on Wednesday that its AI-based fully automatic contouring solution, AVIEW RT ACS, passed FDA 510 (k) certification.The FDA 510 (k) is a premarket approval required by all Class I, II, and III medical devices intended f
Ildong Pharmaceutical said that Japan's Ministry of Health, Labour and Welfare has granted emergency use approval (EUA) for Shionogi & Co’s Xocova, an oral Covid-19 treatment Ildong has been co-developing.Shionogi applied for conditional approval for Xocova to Japan's Ministry of Health, Labor and W
As human life expectancy increases with the development of science and technology, concerns about “death with dignity” are deepening from the aspect of medical ethics.Death with dignity and the right to self-determination has recently emerged as major issue of medical ethics.Previously, the matter m
Korea added 72,873 new Covid-19 infections, including 81 cases from abroad, bringing the total caseload to 26,654,729, according to the Korea Disease Control and Prevention Agency (KDCA). The figure is the highest since Sept. 14, when the country reported 93,949 cases.The nation also reported 45 mor
As the Covid-19 pandemic goes through its seventh wave in Korea, the one thing that persists is some people’s long Covid or post-Covid symptoms. While some are lucky to just be sick for one or two weeks, others suffer from these symptoms for an extended time.A 42-year-old woman living in Seoul who p
A research team at the Korea Advanced Institute of Science and Technology (KAIST) said it developed fabric-based wearable blue organic light-emitting diodes (OLEDs) that can treat jaundice in newborns.Hospitals currently treat neonatal jaundice in a variety of ways, including phototherapy, drug admi
Celltrion Healthcare said multi-country real-world data proved the effectiveness and safety of Truxima (ingredient: rituximab, CT-P10), an anticancer biosimilar, in non-Hodgkin’s lymphoma (NHL) patients. EJHaem, an international academic journal, published a study of the effectiveness and safety of
Nurses and students at nursing schools gathered in front of the National Assembly on Monday, and executives at the Korean Nurses Association (KNA) shaved their heads to show determination.Some 50,000 nurses and nursing school students chanted slogans, such as, “The National Assembly must stop partis
Takeda Pharmaceutical Korea has proven the efficacy and safety of Ninlaro, a multiple myeloma treatment (ingredient: ixazomib), in Koreans through real-world data.The study included 60 patients who received Ninlaro in combination with two other treatments (ixazomib + lenalidomide + dexamethasone) at
GSK has decided to voluntarily withdraw Juluca (dolutegravir/rilpivirine), the company’s first-ever two-drug regimen of HIV treatment, three years and nine months after it won the permit in Korea.According to the Ministry of Food and Drug Safety, GSK withdrew the permit of Juluca Tab. on Monday.Acco
Janssen Korea and Illumina Korea are considering trimming their payroll, following the moves of other Korean offshoots of multinational pharmaceutical firms.According to industry sources, Janssen Korea is trying to reduce its workforce through an early retirement program (ERP)."I have heard that our
Wells Bio, a subsidiary of Access Bio, said on Tuesday that it has recently obtained approval from the Ministry of Food and Drug Safety (MFDS) for its kit that can diagnose tsutsugamushi bacterial infections.Tsutsugamushi is an acute febrile disease transmitted by larvae of chigger mites carrying ts
It may be safe to say that the development of PARP (Poly ADP-ribose polymerase) inhibitors has changed the treatment environment for ovarian cancer. That’s because the development extended the progression-free survival period and other prognoses of ovarian cancer patients.After it was known that PAR
Seegene, a company specializing in molecular diagnostics, said it won a 62.7 billion won ($46.1 million) contract to supply its diagnostic reagents to Italy. Seegene said Italy Arrow Diagnostics S.r.l. had been selected as a supplier in the diagnostic reagent bidding, which the Tuscany government ho